Lv6
2688 积分 2024-07-15 加入
Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial
7天前
已完结
Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes
10天前
已完结
Mazdutide versus placebo in Chinese adults with type 2 diabetes
10天前
已完结
Relationship between the insulin use and stigma in type 2 diabetes mellitus
12天前
已完结
Perioperative and Periprocedural Management of Once-Weekly Insulin Treated Patients
2个月前
已完结
From cancer to Alzheimer’s: could a renewed focus on energy transform biomedicine?
4个月前
已完结
预混胰岛素转为基础胰岛素联合口服降糖药治疗方案的2型糖尿病患者的临床特征分析
5个月前
已完结
Comparison of Insulin Titration Strategies for Glycemic Control in Type 2 Diabetes: A Systematic Review and Network Meta-analysis
6个月前
已完结
Glycemia risk index (GRI): a metric designed to facilitate the interpretation of continuous glucose monitoring data: a narrative review
7个月前
已完结
Once‑weekly IcoSema versus once‑weekly insulin icodec in type 2 diabetes management (COMBINE 1): an open‑label, multicentre, treat‑to‑target, randomised, phase 3a trial
7个月前
已完结
皖公网安备34019202002308
